Regen BioPharma, Inc.
RGBP · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 0.4% | 37.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 78.8% | 85.4% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -176.7% | 1,318.5% | 1,270.8% | -3,620% |
| Net Income | -$0 | $0 | $0 | -$0 |
| % Margin | -282.4% | 432.9% | 945.6% | -3,951.7% |
| EPS Diluted | -0.16 | 0.14 | 0.36 | -1.69 |
| % Growth | -214.3% | -61.1% | 121.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |